Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1140.03 | +0.4% | 668.7K |
 AZN | AstraZeneca PLC | $250.7b | $163.15 | +0.6% | 2.1M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $12.5b | $525.62 | +0.6% | 120.3K |
 PTGX | Protagonist Therapeutics, Inc | $9.6b | $143.21 | +0.3% | 157.1K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $6.3b | $63.58 | +2.2% | 1.1M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $6.2b | $76.77 | +2.1% | 182.3K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 VKTX | Viking Therapeutics, Inc | $4.0b | $29.96 | +0.9% | 1.5M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.1b | $21.12 | +0.2% | 670.2K |
 MBX | MBX Biosciences, Inc. Common Stock | $3.0b | $61.13 | +0.5% | 769.7K |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.5b | $27.65 | -4.2% | 424.4K |
 SEPN | Septerna, Inc. Common Stock | $1.7b | $38.20 | -1.0% | 114.3K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $24.14 | -0.7% | 184.6K |
 MNKD | Mannkind Corporation | $1.3b | $3.58 | +0.7% | 922.7K |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.0b | $2.02 | +1.0% | 1.2M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $0.7b | $10.45 | +0.8% | 297.2K |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.7b | $6.67 | -0.1% | 57.9K |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $3.25 | +0.8% | 1.8M |
 BIOA | BioAge Labs, Inc. Common Stock | $446.6m | $7.70 | -5.3% | 359.6K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $437.2m | $3.94 | -4.5% | 1.0M |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $253.5m | $1.81 | -1.4% | 813.7K |
 ORMP | Oramed Pharmaceuticals Inc. | $205.1m | $4.61 | +0.1% | 76.5K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $150.6m | $0.90 | -1.8% | 783.4K |
 BMEA | Biomea Fusion, Inc. Common Stock | $140.3m | $1.75 | -2.8% | 1.0M |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $132.3m | $30.27 | +0.1% | 42.9K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $130.2m | $5.24 | +3.9% | 27.8K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $125.4m | $1.24 | 0.0% | 62.9K |
 GUTS | Fractyl Health, Inc. Common Stock | $112.5m | $0.57 | +1.2% | 632.2K |
 TENX | Tenax Therapeutics, Inc. | $66.6m | $1.89 | +3.6% | 1.2M |
 VERU | Veru Inc. | $45.2m | $2.34 | 0.0% | 79.4K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $38.8m | $4.95 | +1.8% | 22.9K |
 GRDX | GridAI Technologies Corp. Common Stock | $24.7m | $3.00 | 0.0% | 22.0K |
 LPCN | Lipocine Inc. | $19.4m | $2.21 | +1.1% | 26.1K |
 NCEL | NewcelX Ltd. Ordinary Shares | $19.4m | $3.27 | 0.0% | 4.2K |
 MTVA | MetaVia Inc. Common Stock | $12.1m | $1.57 | +0.6% | 38.7K |
 SKYE | Skye Bioscience, Inc. Common Stock | $7.9m | $1.85 | -8.1% | 68.6K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $7.1m | $4.26 | 0.0% | 7.2K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $4.7m | $1.07 | +1.9% | 40.0K |
 GLMD | Galmed Pharmaceuticals Ltd. | $4.3m | $4.59 | 0.0% | N/A |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $4.2m | $1.33 | -4.3% | 29.8K |
 ELAB | PMGC Holdings Inc. Common Stock | $4.1m | $4.87 | 0.0% | 8.3K |